• Article

TD-5108, a selective 5-HT4 agonist, is consistently better than placebo regardless of response definition in patients with chronic constipation

Citation

Goldberg, M. R., Li, Y-P., Pitzer, K., Johanson, J. F., Mangel, A. W., & Kitt, M. M. (2008). TD-5108, a selective 5-HT4 agonist, is consistently better than placebo regardless of response definition in patients with chronic constipation. Gastroenterology, 134(4), A545-A545.